Gene ontology annotations for HIST2H2AB |
|
Experiment description of studies that identified HIST2H2AB in exosomes |
1 |
Experiment ID |
489 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 6 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
2 |
Experiment ID |
490 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 7 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
3 |
Experiment ID |
491 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
4 |
Experiment ID |
492 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Cd9|Cd81|Cd63|Gapdh|Sdcbp|Lamp1|Aqp1|Rab5a|Icam1|Cd82|Itga2b|Tsg101|Lamp2|Rab35|Flot1|Flot2|Cd151|Rab5b|Tfrc|Uchl1
|
Enriched markers |
✔
Canx
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Rattus norvegicus |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Bone marrow mesenchymal stem cells |
Sample name |
BMSC - Passage 9 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
5 |
Experiment ID |
497 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
6 |
Experiment ID |
498 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
7 |
Experiment ID |
282 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
✘
|
Negative markers |
✔
DLS
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25890246
|
Organism |
Homo sapiens |
Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
Journal name |
Methods
|
Publication year |
2015 |
Sample |
Colorectal cancer cells |
Sample name |
LIM1863 - Ultracentrifugation - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Centrifugal concentration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
8 |
Experiment ID |
283 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
✘
|
Negative markers |
✔
DLS
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25890246
|
Organism |
Homo sapiens |
Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
Journal name |
Methods
|
Publication year |
2015 |
Sample |
Colorectal cancer cells |
Sample name |
LIM1863 - Ultracentrifugation - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Centrifugal concentration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
9 |
Experiment ID |
286 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81|EpCAM
|
Enriched markers |
✘
|
Negative markers |
✔
DLS
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25890246
|
Organism |
Homo sapiens |
Experiment description |
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. |
Authors |
"Xu R, Greening DW, Rai A, Ji H, Simpson RJ." |
Journal name |
Methods
|
Publication year |
2015 |
Sample |
Colorectal cancer cells |
Sample name |
LIM1863 - Sequential centrifugal ultrafiltration - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Sequential centrifugal ultrafiltration Centrifugal concentration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
10 |
Experiment ID |
254 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1|CD81
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
MNT-1 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
11 |
Experiment ID |
255 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
G1 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
12 |
Experiment ID |
256 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
501mel |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
13 |
Experiment ID |
257 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
Daju |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
14 |
Experiment ID |
258 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1|CD81
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
SKMEL28 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
15 |
Experiment ID |
259 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
A375M |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
16 |
Experiment ID |
260 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1|CD81
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
1205Lu |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
17 |
Experiment ID |
488 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Homo sapiens |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Mesenchymal stem cells |
Sample name |
UCMSC |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
18 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
19 |
Experiment ID |
144 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
C4-2 - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
20 |
Experiment ID |
146 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
RWPE - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
21 |
Experiment ID |
275 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel sensitive |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.12-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
22 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
23 |
Experiment ID |
63 |
MISEV standards |
✘
|
Biophysical techniques |
✔
AQP2
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19056867
|
Organism |
Homo sapiens |
Experiment description |
Large-scale proteomics and phosphoproteomics of urinary exosomes. |
Authors |
"Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA" |
Journal name |
JASN
|
Publication year |
2009 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
Protein-protein interactions for HIST2H2AB |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
UBE2H |
7328 |
Affinity Capture-MS |
 |
Homo sapiens |
|
2 |
ZBTB38 |
253461 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
3 |
SLFN11 |
91607 |
Proximity Label-MS |
 |
Homo sapiens |
|
4 |
HIST2H2BE |
8349 |
Affinity Capture-MS |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
5 |
XPC |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
6 |
RPSAP58 |
388524 |
Affinity Capture-MS |
 |
Homo sapiens |
|
7 |
H1FNT |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
8 |
HIST1H2BE |
8344 |
Affinity Capture-MS |
 |
Homo sapiens |
|
9 |
ZNF346 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
10 |
RPL30 |
6156 |
Affinity Capture-MS |
 |
Homo sapiens |
|
11 |
SRPK2 |
6733 |
Affinity Capture-MS |
 |
Homo sapiens |
|
12 |
ZNF668 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
13 |
NAA40 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
14 |
RPA2 |
6118 |
Affinity Capture-MS |
 |
Homo sapiens |
|
15 |
RPL13A |
23521 |
Affinity Capture-MS |
 |
Homo sapiens |
|
16 |
RPL37A |
6168 |
Affinity Capture-MS |
 |
Homo sapiens |
|
17 |
HIST1H2BJ |
8970 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
18 |
RPS19 |
6223 |
Affinity Capture-MS |
 |
Homo sapiens |
|
19 |
KIF20A |
10112 |
Affinity Capture-MS |
 |
Homo sapiens |
|
20 |
HIST1H2BB |
3018 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
21 |
BRD2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
22 |
RPL14 |
9045 |
Affinity Capture-MS |
 |
Homo sapiens |
|
23 |
HIST3H2BB |
128312 |
Affinity Capture-MS |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
24 |
SRFBP1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
25 |
ZNF398 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
26 |
CAMTA2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
27 |
HIST2H2BF |
440689 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
28 |
APP |
351 |
Reconstituted Complex |
 |
Homo sapiens |
Reconstituted Complex |
 |
Homo sapiens |
|
29 |
GOLGA7 |
51125 |
Affinity Capture-MS |
 |
Homo sapiens |
|
30 |
HIST2H3A |
333932 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
31 |
HIST1H2BD |
3017 |
Affinity Capture-MS |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
32 |
B3GNT2 |
10678 |
Affinity Capture-MS |
 |
Homo sapiens |
|
33 |
KIF23 |
9493 |
Affinity Capture-MS |
 |
Homo sapiens |
|
34 |
MCM2 |
4171 |
Affinity Capture-MS |
 |
Homo sapiens |
|
35 |
ELOVL1 |
64834 |
Affinity Capture-MS |
 |
Homo sapiens |
|
36 |
PRC1 |
9055 |
Affinity Capture-MS |
 |
Homo sapiens |
|
37 |
SUV39H1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
38 |
ANOS1 |
3730 |
Affinity Capture-MS |
 |
Homo sapiens |
|
39 |
H2AFY2 |
55506 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
40 |
OBSL1 |
23363 |
Affinity Capture-MS |
 |
Homo sapiens |
|
41 |
HMGA1 |
3159 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
42 |
RTN1 |
6252 |
Affinity Capture-MS |
 |
Homo sapiens |
|
43 |
TMEM192 |
201931 |
Affinity Capture-MS |
 |
Homo sapiens |
|
44 |
BRD4 |
23476 |
Affinity Capture-MS |
 |
Homo sapiens |
|
45 |
ATG16L1 |
55054 |
Affinity Capture-MS |
 |
Homo sapiens |
|
46 |
HIST1H4I |
8294 |
Affinity Capture-MS |
 |
Homo sapiens |
|
47 |
KLHL20 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
48 |
MED27 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
49 |
MYCN |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
50 |
MAK16 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
51 |
RPL19 |
6143 |
Affinity Capture-MS |
 |
Homo sapiens |
|
52 |
KIF14 |
9928 |
Affinity Capture-MS |
 |
Homo sapiens |
|
53 |
ZCRB1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
54 |
PPM1B |
5495 |
Affinity Capture-MS |
 |
Homo sapiens |
|
55 |
H2AFZ |
3015 |
Affinity Capture-MS |
 |
Homo sapiens |
|
56 |
LOC102724334 |
102724334 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
57 |
HNF1A |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
58 |
NUMA1 |
4926 |
Affinity Capture-MS |
 |
Homo sapiens |
|
59 |
HIST1H4A |
8359 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
60 |
TOP3B |
8940 |
Affinity Capture-MS |
 |
Homo sapiens |
|
61 |
ECT2 |
1894 |
Affinity Capture-MS |
 |
Homo sapiens |
|
62 |
RPL4 |
6124 |
Affinity Capture-MS |
 |
Homo sapiens |
|
63 |
ZC3H3 |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
64 |
RPS10 |
6204 |
Affinity Capture-MS |
 |
Homo sapiens |
|
65 |
RBM4B |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
66 |
YBX2 |
51087 |
Affinity Capture-MS |
 |
Homo sapiens |
|
67 |
MAPRE1 |
22919 |
Affinity Capture-MS |
 |
Homo sapiens |
|
68 |
PURG |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
69 |
RNF146 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
70 |
HIST1H3E |
8353 |
Affinity Capture-MS |
 |
Homo sapiens |
|
71 |
HIST1H2AM |
8336 |
Affinity Capture-MS |
 |
Homo sapiens |
|
72 |
H2AFJ |
55766 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
73 |
CFDP1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
74 |
RPL35 |
11224 |
Affinity Capture-MS |
 |
Homo sapiens |
|
75 |
FAM118B |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
76 |
CHMP4B |
128866 |
Affinity Capture-MS |
 |
Homo sapiens |
|
77 |
NELFE |
7936 |
Affinity Capture-MS |
 |
Homo sapiens |
|
78 |
BTF3 |
689 |
Affinity Capture-MS |
 |
Homo sapiens |
|
79 |
HMGN1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
80 |
RPL31 |
6160 |
Affinity Capture-MS |
 |
Homo sapiens |
|
81 |
FAM24B |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
82 |
HIST1H1E |
3008 |
Affinity Capture-MS |
 |
Homo sapiens |
|
83 |
CBX6 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
84 |
HIST1H1C |
3006 |
Affinity Capture-MS |
 |
Homo sapiens |
|
85 |
HIST1H2BG |
8339 |
Proximity Label-MS |
 |
Homo sapiens |
|
86 |
ENO1 |
2023 |
Affinity Capture-RNA |
 |
Homo sapiens |
|
87 |
LYAR |
55646 |
Affinity Capture-MS |
 |
Homo sapiens |
|
88 |
RPLP0 |
6175 |
Affinity Capture-MS |
 |
Homo sapiens |
|
89 |
POLB |
5423 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
90 |
MAGEB2 |
4113 |
Affinity Capture-MS |
 |
Homo sapiens |
|
91 |
MYBBP1A |
10514 |
Affinity Capture-MS |
 |
Homo sapiens |
|
92 |
PPM1G |
5496 |
Affinity Capture-MS |
 |
Homo sapiens |
Proximity Label-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
93 |
HIST1H2AB |
8335 |
Affinity Capture-MS |
 |
Homo sapiens |
|
94 |
RPL11 |
6135 |
Affinity Capture-MS |
 |
Homo sapiens |
|
95 |
ANLN |
54443 |
Affinity Capture-MS |
 |
Homo sapiens |
|
96 |
FGFBP1 |
9982 |
Affinity Capture-MS |
 |
Homo sapiens |
|
97 |
HIST1H2AA |
221613 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
98 |
HNRNPD |
3184 |
Affinity Capture-MS |
 |
Homo sapiens |
|
99 |
HIST1H3F |
8968 |
Affinity Capture-MS |
 |
Homo sapiens |
|
100 |
HIST1H3A |
8350 |
Affinity Capture-MS |
 |
Homo sapiens |
|
101 |
FANCD2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
102 |
PIGT |
51604 |
Affinity Capture-MS |
 |
Homo sapiens |
|
103 |
RPS2 |
6187 |
Affinity Capture-MS |
 |
Homo sapiens |
|
104 |
RC3H2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
105 |
SMARCA5 |
8467 |
Affinity Capture-Western |
 |
Homo sapiens |
|
106 |
SRSF4 |
6429 |
Affinity Capture-MS |
 |
Homo sapiens |
|
107 |
WBSCR22 |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
108 |
SRSF1 |
6426 |
Affinity Capture-MS |
 |
Homo sapiens |
| | | |